ASIA-PACIFIC MEDICAL ENZYMES MARKET 2022-2028

Lifesciences | Diagnostic & Biotechnology

ASIA-PACIFIC MEDICAL ENZYMES MARKET 2022-2028

Market by Product Type, Application, and Country Outlook | Forecast 2022-2028

Request For Customization

Request Custom Report

Request Custom Report

Enquire before buying

Enquire Before Buying

As per Triton’s report, the market for medical enzymes in the Asia-Pacific is estimated to advance with a CAGR of 7.67% over the forecasting duration from 2022 to 2028.


Report scope can be customized per your requirements. Request For Customization

The countries analyzed in this region include:

•         South Korea

•         ASEAN Countries

•         China

•         India

•         Japan

•         Australia & New Zealand

•         Rest of Asia-Pacific

One of the main factors projected to fuel the expansion of the medical enzymes market in the Asia-Pacific is the poor dietary habits of individuals in nations like China, India, and Japan. Poor eating habits have contributed to a number of health problems, including weight gain and digestive ailments in the region. This has led to an increased demand for medical enzymes for treatment, and is expected to foster the market’s growth in the forthcoming years.

The prevalence of hypertension, diabetes, and cardiovascular illnesses is on the rise in China. These conditions can be treated and managed using medical enzymes. Thus, the country’s medical enzymes market is anticipated to grow as a result of rising disease rates. Other factors, including the expanding biotech industry, development of healthcare infrastructure, and a vast population, also support the market’s growth.

South Korea is faced with challenges, such as the nation’s increasingly aging population, high rates of childhood obesity and harmful health behaviors like smoking & drinking, which need to be addressed. The majority of the diseases affecting Koreans are non-communicable, including Alzheimer’s, liver and lung cancer, heart disease, and cerebrovascular disease. The use of enzymes in the treatment of various illnesses is thus anticipated to fuel the studied market’s expansion in the coming years.

Digestive enzymes can break down lipids, proteins, and carbohydrates. A few examples include maltase, amylase, sucrose, peptidase, lipase, nuclease, and other enzymes. Their usage in the treatment of digestive problems, like lactose intolerance, to cystic fibrosis and pancreatic insufficiency, increases the market segment’s potential for growth. During the projected period, the rising elderly population, increased awareness, and the rising incidence of gastrointestinal illnesses such as constipation & irritable bowel syndrome will all contribute to this segment’s growth.

The report assesses the market based on application and product type. Here, the product type segment is divided into digestive enzyme, hydrolase, thrombolytic enzyme, and endonuclease.

The eminent players in the medical enzymes market include Advanced Enzymes, BASF SE, Thermofisher Scientific Inc, Novozymes, Sanofi SA, Codexis, and Novus.

Advanced Enzymes is one of the biggest enzyme producers in India. It produces, markets, and engages in research & development of more than 400 products derived from roughly 65 local enzymes and probiotics. Human nutrition, animal nutrition, probiotics, food processing, and non-food processing sectors are the company’s main business segments. Advanced Enzymes has 5 manufacturing facilities, 4 fully-owned direct subsidiaries, 5 step-down fully-owned subsidiaries, and 3 partially owned subsidiaries. Founded in 1989, the company is headquartered in Thane, Maharashtra.

 

Key deliverables of the report:

      Market CAGR during the forecasting years 2022-2028

      Detailed data highlighting key insights, industry components, and market strategies


     Comprehensive information and estimation of the medical enzymes market revenue growth in Asia-Pacific and its influence on the parent market


      In-depth study of forthcoming trends in consumer behavioral patterns


      A meticulous analysis of the competitive landscape, vendor scorecard, and Porter’s Five Forces Model


     A wide-ranging study of factors that will challenge the Asia-Pacific medical enzymes market’s growth during the upcoming years

Want to get specific insights? Our team of analysts can customize this report based on your preferences. Connect with us here

Related Reports

ASIA PACIFIC AESTHETIC LASER MARKET 2019-2027
Lifesciences

ASIA PACIFIC AESTHETIC LASER MARKET 2019-2027

Market By Type, Application, E ..

VIEW REPORT
ASIA PACIFIC BIOCHIPS MARKET 2019-2027
Lifesciences

ASIA PACIFIC BIOCHIPS MARKET 2019-2027

Market By Type, Substrate Mate ..

VIEW REPORT
ASIA PACIFIC BIOPSY DEVICE MARKET 2019-2027
Lifesciences

ASIA PACIFIC BIOPSY DEVICE MARKET 2019-2027

Market By Device Type, Therape ..

VIEW REPORT
ASIA PACIFIC DNA VACCINES MARKET 2019-2027
Lifesciences

ASIA PACIFIC DNA VACCINES MARKET 2019-2027

Market By Type, Application, T ..

VIEW REPORT
ASIA-PACIFIC 3D CELL CULTURE MARKET 2019-2027
Lifesciences

ASIA-PACIFIC 3D CELL CULTURE MARKET 2019-2027

Market By Technology, Applicat ..

VIEW REPORT
ASIA-PACIFIC AIRWAY CLEARANCE SYSTEM MARKET 2019-2028
Lifesciences

ASIA-PACIFIC AIRWAY CLEARANCE SYSTEM MARKET 2019-2028

Market By Application, Type, E ..

VIEW REPORT

Table of Content

1.    ASIA-PACIFIC MEDICAL ENZYMES MARKET - SUMMARY

2.    INDUSTRY OUTLOOK

2.1. IMPACT OF COVID-19 ON THE MEDICAL ENZYMES MARKET

2.2. KEY INSIGHTS

2.2.1.   ADVANCEMENTS IN ENZYME ENGINEERING

2.2.2.   INCREASED DEMAND IN THE PHARMACEUTICAL SECTOR

2.3. PORTER'S FIVE FORCES ANALYSIS

2.3.1.   THREAT OF NEW ENTRANTS

2.3.2.   THREAT OF SUBSTITUTES

2.3.3.   BARGAINING POWER OF BUYERS

2.3.4.   BARGAINING POWER OF SUPPLIERS

2.3.5.   THREAT OF COMPETITIVE RIVALRY

2.4. KEY IMPACT ANALYSIS

2.4.1.   PRICE

2.4.2.   QUALITY

2.4.3.   USAGE

2.5. MARKET ATTRACTIVENESS INDEX

2.6. VENDOR SCORECARD

2.7. INDUSTRY COMPONENTS

2.7.1.   RESEARCH AND DEVELOPMENT

2.7.2.   OPERATIONS

2.7.3.   OUTBOUND LOGISTICS

2.8. REGULATORY FRAMEWORK

2.9. KEY MARKET STRATEGIES

2.9.1.   MERGERS & ACQUISITIONS

2.9.2.   PRODUCT LAUNCHES & DEVELOPMENTS

2.9.3.   PARTNERSHIPS & AGREEMENTS

2.9.4.   BUSINESS EXPANSIONS & DIVESTITURES

2.10. MARKET DRIVERS

2.10.1.  RISING INVESTMENTS IN RESEARCH AND DEVELOPMENT

2.10.2.  RISING AGING POPULATION AND OCCURRENCE OF CHRONIC DISEASES

2.10.3.  INCREASING APPLICATIONS IN THE PHARMACEUTICAL INDUSTRY

2.11. MARKET CHALLENGES

2.11.1. STRICT REGULATIONS

2.11.2. SAFETY CONCERNS WHILE HANDLING ENZYMES

2.12. MARKET OPPORTUNITIES

2.12.1. RISING HEALTH ISSUES AND GROWING AWARENESS

2.12.2. RISING DEMAND FOR SPECIALTY ENZYMES

3.    ASIA-PACIFIC MEDICAL ENZYMES MARKET OUTLOOK - BY PRODUCT TYPE

3.1. HYDROLASE

3.1.1.   HYALURONIDASE

3.1.2.   LYSOZYMES

3.1.3.   OTHER HYDROLASES ENZYMES

3.2. THROMBOLYTIC ENZYME

3.2.1.   STREPTOKINASE

3.2.2.   UROKINASE

3.2.3.   OTHER THROMBOLYTIC ENZYMES

3.3. DIGESTIVE ENZYME

3.3.1.   LACTASE

3.3.2.   L-ASPARAGINASE

3.3.3.   OTHER DIGESTIVE ENZYMES

3.4. ENDONUCLEASE

3.4.1.   BENZONASE

3.4.2.   OTHER ENDONUCLEASES

4.    ASIA-PACIFIC MEDICAL ENZYMES MARKET OUTLOOK - BY APPLICATION

4.1. DISEASE TREATMENT

4.2. DIAGNOSTIC TOOLS

4.3. BIOMEDICAL RESEARCH

4.4. OTHER APPLICATIONS

5.    ASIA-PACIFIC MEDICAL ENZYMES MARKET – COUNTRY OUTLOOK

5.1.  CHINA

5.2.  JAPAN

5.3.  INDIA

5.4.  SOUTH KOREA

5.5.  ASEAN COUNTRIES

5.6.  AUSTRALIA & NEW ZEALAND

5.7.  REST OF ASIA-PACIFIC

6.    COMPETITIVE LANDSCAPE

6.1. BASF SE

6.2. DUPONT

6.3. ROCHE HOLDING AG

6.4. NOVOZYMES

6.5. DSM

6.6. SANOFI SA

6.7. CODEXIS

6.8. ADVANCED ENZYMES

6.9. AMANO ENZYME

6.10. BBI SOLUTIONS

6.11. THERMOFISHER SCIENTIFIC INC

6.12. CPC BIOTECH

6.13. NOVUS

6.14. BRAIN BIOTECH AG

6.15. SEKISUI

7.    RESEARCH METHODOLOGY & SCOPE

7.1. RESEARCH SCOPE & DELIVERABLES

7.2. SOURCES OF DATA

7.3. RESEARCH METHODOLOGY

List of Tables

TABLE 1: ASIA-PACIFIC MEDICAL ENZYMES MARKET, BY COUNTRY, 2022-2028 (IN $ MILLION)

TABLE 2: APPLICATIONS OF ENZYMES IN THE PHARMACEUTICALS INDUSTRY

TABLE 3: VENDOR SCORECARD

TABLE 4: REGULATORY FRAMEWORK

TABLE 5: LIST OF MERGERS & ACQUISITIONS

TABLE 6: LIST OF PRODUCT LAUNCHES & DEVELOPMENTS

TABLE 7: LIST OF PARTNERSHIPS & AGREEMENTS

TABLE 8: LIST OF BUSINESS EXPANSIONS & DIVESTITURES

TABLE 9: MEDICAL APPLICATION OF VARIOUS ENZYMES

TABLE 10: ASIA-PACIFIC MEDICAL ENZYMES MARKET, BY PRODUCT TYPE, 2022-2028 (IN $ MILLION)

TABLE 11: ASIA-PACIFIC MEDICAL ENZYMES MARKET, BY HYDROLASE ENZYME, 2022-2028 (IN $ MILLION)

TABLE 12: ASIA-PACIFIC MEDICAL ENZYMES MARKET, BY THROMBOLYTIC ENZYME, 2022-2028 (IN $ MILLION)

TABLE 13: ASIA-PACIFIC MEDICAL ENZYMES MARKET, BY DIGESTIVE ENZYME, 2022-2028 (IN $ MILLION)

TABLE 14: ASIA-PACIFIC MEDICAL ENZYMES MARKET, BY ENDONUCLEASE, 2022-2028 (IN $ MILLION)

TABLE 15: ASIA-PACIFIC MEDICAL ENZYMES MARKET, BY APPLICATION, 2022-2028 (IN $ MILLION)

TABLE 16: ASIA-PACIFIC MEDICAL ENZYMES MARKET, BY COUNTRY, 2022-2028 (IN $ MILLION)

List of Figures

FIGURE 1: KEY BUYING IMPACT ANALYSIS

FIGURE 2: MARKET ATTRACTIVENESS INDEX

FIGURE 3: INDUSTRY COMPONENTS

FIGURE 4: ASIA-PACIFIC MEDICAL ENZYMES MARKET, BY PRODUCT TYPE, 2021 & 2028 (IN %)

FIGURE 5: ASIA-PACIFIC MEDICAL ENZYMES MARKET, BY HYDROLASE, 2022-2028 (IN $ MILLION)

FIGURE 6: ASIA-PACIFIC MEDICAL ENZYMES MARKET, BY HYDROLASE ENZYME, 2021 & 2028 (IN %)

FIGURE 7: ASIA-PACIFIC MEDICAL ENZYMES MARKET, BY HYALURONIDASE, 2022-2028 (IN $ MILLION)

FIGURE 8: ASIA-PACIFIC MEDICAL ENZYMES MARKET, BY LYSOZYMES, 2022-2028 (IN $ MILLION)

FIGURE 9: ASIA-PACIFIC MEDICAL ENZYMES MARKET, BY OTHER HYDROLASES ENZYMES, 2022-2028 (IN $ MILLION)

FIGURE 10: ASIA-PACIFIC MEDICAL ENZYMES MARKET, BY THROMBOLYTIC ENZYME, 2022-2028 (IN $ MILLION)

FIGURE 11: ASIA-PACIFIC MEDICAL ENZYMES MARKET, BY THROMBOLYTIC ENZYME, 2021 & 2028 (IN %)

FIGURE 12: ASIA-PACIFIC MEDICAL ENZYMES MARKET, BY STREPTOKINASE, 2022-2028 (IN $ MILLION)

FIGURE 13: ASIA-PACIFIC MEDICAL ENZYMES MARKET, BY UROKINASE, 2022-2028 (IN $ MILLION)

FIGURE 14: ASIA-PACIFIC MEDICAL ENZYMES MARKET, BY OTHER THROMBOLYTIC ENZYMES, 2022-2028 (IN $ MILLION)

FIGURE 15: ASIA-PACIFIC MEDICAL ENZYMES MARKET, BY DIGESTIVE ENZYME, 2022-2028 (IN $ MILLION)

FIGURE 16: ASIA-PACIFIC MEDICAL ENZYMES MARKET, BY DIGESTIVE ENZYME, 2021 & 2028 (IN %)

FIGURE 17: ASIA-PACIFIC MEDICAL ENZYMES MARKET, BY LACTASE, 2022-2028 (IN $ MILLION)

FIGURE 18: ASIA-PACIFIC MEDICAL ENZYMES MARKET, BY L-ASPARAGINASE, 2022-2028 (IN $ MILLION)

FIGURE 19: ASIA-PACIFIC MEDICAL ENZYMES MARKET, BY OTHER DIGESTIVE ENZYMES, 2022-2028 (IN $ MILLION)

FIGURE 20: ASIA-PACIFIC MEDICAL ENZYMES MARKET, BY ENDONUCLEASE, 2022-2028 (IN $ MILLION)

FIGURE 21: ASIA-PACIFIC MEDICAL ENZYMES MARKET, BY ENDNUCLEASE ENZYME, 2021 & 2028 (IN %)

FIGURE 22: ASIA-PACIFIC MEDICAL ENZYMES MARKET, BY BENZONASE, 2022-2028 (IN $ MILLION)

FIGURE 23: ASIA-PACIFIC MEDICAL ENZYMES MARKET, BY OTHER ENDONUCLEASES, 2022-2028 (IN $ MILLION)

FIGURE 24: ASIA-PACIFIC MEDICAL ENZYMES MARKET, BY APPLICATION, 2021 & 2028 (IN %)

FIGURE 25: ASIA-PACIFIC MEDICAL ENZYMES MARKET, BY DISEASE TREATMENT, 2022-2028 (IN $ MILLION)

FIGURE 26: ASIA-PACIFIC MEDICAL ENZYMES MARKET, BY DIAGNOSTIC TOOLS, 2022-2028 (IN $ MILLION)

FIGURE 27: ASIA-PACIFIC MEDICAL ENZYMES MARKET, BY BIOMEDICAL RESEARCH, 2022-2028 (IN $ MILLION)

FIGURE 28: ASIA-PACIFIC MEDICAL ENZYMES MARKET, BY OTHER APPLICATIONS, 2022-2028 (IN $ MILLION)

FIGURE 29: ASIA-PACIFIC MEDICAL ENZYMES MARKET, COUNTRY OUTLOOK, 2021 & 2028 (IN %)

FIGURE 30: CHINA MEDICAL ENZYMES MARKET 2022-2028 (IN $ MILLION)

FIGURE 31: JAPAN MEDICAL ENZYMES MARKET 2022-2028 (IN $ MILLION)

FIGURE 32: INDIA MEDICAL ENZYMES MARKET 2022-2028 (IN $ MILLION)

FIGURE 33: SOUTH KOREA MEDICAL ENZYMES MARKET 2022-2028 (IN $ MILLION)

FIGURE 34: ASEAN COUNTRIES MEDICAL ENZYMES MARKET 2022-2028 (IN $ MILLION)

FIGURE 35: AUSTRALIA & NEW ZEALAND MEDICAL ENZYMES MARKET 2022-2028 (IN $ MILLION)

FIGURE 36: REST OF ASIA-PACIFIC MEDICAL ENZYMES MARKET 2022-2028 (IN $ MILLION)

Purchase Options

  • Licence Type
  • Price
  • User/Sharing
  • Printing
  • Delivery Formats
  • Free customization (Pre-sale)
  • Analyst hour support (Post Sale)
  • Customized notification for newly published report
  • Free report on update (within 180 days)

Single User PDF

$1,500.00

  • User/Sharing
  • Restricted to one authorized user
  • Printing
  • Not printable
  • Delivery Formats
  • Pdf
  • Free customization (Pre-sale)
  • 10% Free customization
  • Analyst hour support (Post Sale)
  • 3 hours
  • Customized notification (newly published)
  • Free report on update (within 180 days)

Enterprise Online/PDF

$2,200.00

  • User/Sharing
  • Unlimited
  • Printing
  • Unlimited
  • Delivery Formats
  • Pdf and market estimation excel
  • Free customization (Pre-sale)
  • 20% Free customization
  • Analyst hour support (Post Sale)
  • 8 hour
  • Customized notification (newly published)
  • Free report on update (within 180 days)

Request free Sample

SUBMIT REQUEST
Request Custom Report

Request Custom Report

Enquire before buying

Enquire Before Buying

;